Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.51 - $117.79 $120,775 - $27.9 Million
-236,814 Reduced 87.2%
34,766 $15,000
Q1 2022

May 16, 2022

SELL
$0.61 - $0.75 $100,650 - $123,750
-165,000 Reduced 37.79%
271,580 $198,000
Q4 2021

Feb 14, 2022

SELL
$0.66 - $1.1 $231,825 - $386,375
-351,250 Reduced 44.58%
436,580 $288,000
Q3 2019

Nov 14, 2019

SELL
$0.72 - $1.31 $35,978 - $65,460
-49,970 Reduced 5.96%
787,830 $748,000
Q1 2018

May 15, 2018

SELL
$1.92 - $2.4 $61,824 - $77,280
-32,200 Reduced 3.7%
837,800 $1.64 Million
Q4 2017

Feb 14, 2018

BUY
$1.84 - $2.32 $1.6 Million - $2.02 Million
870,000
870,000 $1.84 Million

Others Institutions Holding SNGX

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About SOLIGENIX, INC.


  • Ticker SNGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,105,200
  • Market Cap $152M
  • Description
  • Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has c...
More about SNGX
Track This Portfolio

Track Knoll Capital Management, LLC Portfolio

Follow Knoll Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knoll Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Knoll Capital Management, LLC with notifications on news.